Nitroxazepine

Nitroxazepine
Systematic (IUPAC) name
10-[3-(dimethylamino)propyl]-2-nitrodibenzo[b,f][1,4]oxazepin-11(​10H)-one
Clinical data
Pregnancy cat.  ?
Legal status Prescription only
Routes Oral
Identifiers
CAS number 16398-39-3
ATC code None
PubChem CID 27857
ChemSpider 25919
Chemical data
Formula C18H19N3O4 
Mol. mass 341.36 g/mol
SMILES eMolecules & PubChem

Nitroxazepine (trade name Sintamil) is a tricyclic antidepressant (TCA) which was introduced by Ciba-Geigy (now Novartis) for the treatment of depression in India in 1982.[1] It is also indicated for the treatment of nocturnal enuresis.[1] Nitroxazepine acts as a serotonin-norepinephrine reuptake inhibitor and has similar effects to imipramine, but with certain advantages, such as lower anticholinergic side effects.[2][3][4]

See also

References